EYPT
EYPT
NASDAQ · Pharmaceuticals

Eyepoint Inc

$14.63
+0.25 (+1.74%)
As of Jun 24, 2:05 PM ET ·
Financial Highlights (FY 2026)
Revenue
35.86M
Net Income
-265,109,767
Gross Margin
93.4%
Profit Margin
-739.4%
Rev Growth
-8.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 93.4% 93.4% 35.0% 35.0%
Operating Margin -776.0% -698.4% 22.3% 21.7%
Profit Margin -739.4% -702.5% 24.9% 20.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 35.86M 39.33M 211.34M 213.20M
Gross Profit 33.49M 36.74M 73.87M 74.52M
Operating Income -278,238,616 -274,667,932 47.20M 46.31M
Net Income -265,109,767 -261,707,568 52.60M 44.43M
Gross Margin 93.4% 93.4% 35.0% 35.0%
Operating Margin -776.0% -698.4% 22.3% 21.7%
Profit Margin -739.4% -702.5% 24.9% 20.8%
Rev Growth -8.8% -8.8% -6.2% +21.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 107.95M 96.71M
Total Equity 420.20M 423.48M
D/E Ratio 0.26 0.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -275,582,888 -287,159,968 60.54M 58.90M
Free Cash Flow 38.74M 42.58M